Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
Denise Rezende, Product Manager of Systems Worldwide Marketing, Hemostasis at Werfen North America, shared a post on LinkedIn:
”Great topic and a very relevant discussion!
What should clinicians do when thrombosis occurs despite DOAC therapy?
Looking forward to hearing the perspectives of international experts and learning more about the clinical management and different approaches to these challenging situations.
Another great educational initiative supported by Werfen.”
Werfen shared a post on LinkedIn:
”What should clinicians do when thrombosis occurs despite DOAC therapy?
Join the upcoming ISTH webinar, ‘Breakthrough Thrombosis in DOACs: What to do Next,’ where international experts will explore the latest perspectives on managing these challenging cases.
August 19, 2026 | 12:00 PM UTC
Werfen is proud to support educational initiatives that advance understanding in thrombosis and hemostasis.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis
-
Aug 15, 2026, 16:58Andrew Jackson: Oral Anticoagulants for the Prophylaxis of Catheter-Related Thrombosis
-
Aug 15, 2026, 16:52Understanding Blood Clots During Pregnancy and After Birth – Thrombosis UK
-
Aug 15, 2026, 16:39Liri Seraj: How Summer Dehydration Affects Blood and Thrombosis Risk
-
Aug 15, 2026, 16:20Anoop Singh: When India Became the Key to a Faster Hemophilia A Trial
-
Aug 15, 2026, 16:10Swarup K Chakrabarti: Why the Blood–Brain Barrier Matters for Healthy Aging
-
Aug 15, 2026, 16:00Satya Prakash Yadav: Overcoming Overtreatment in Pediatric Immune Thrombocytopenia
-
Aug 15, 2026, 15:54Clare Craig: Examining Post-Pandemic Healthcare Disruption and Thrombocytopenia Risks
-
Aug 15, 2026, 15:39Dee Sparacio: QI Initiative Reduces Venous Thromboembolism in First-Line Ovarian Cancer Care